KCNQ1 Variant T312I
Summary of observed carriers, functional annotations, and structural context for KCNQ1 T312I. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT1 penetrance
84%
10/13 effective observations
Total carriers
3
3 LQT1 · unaffected
Functional studies
3
Publications with functional data
Variant features alone are equivalent to phenotyping 7 individuals with LQT1 and 3 unaffected individuals.
In silico predictors
| PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density LQT1 (%) |
|---|---|---|---|---|
| -5.54 | 1.0 | 1 | 0.982 | 92 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. BLAST-PSSM reflects evolutionary conservation; more negative values indicate rarer substitutions. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
| Source | Year | Carriers | Unaffected | LQT1 | Other Disease |
|---|---|---|---|---|---|
| 32893267 | 2020 | 2 | None | 2 | None |
| 27114410 | 2016 | 1 | None | None | None |
| 23631430 | 2013 | 3 | None | None | None |
| 23153844 | 2012 | 17 | None | 1 | None |
| 22949429 | 2012 | 1 | None | 1 | None |
| 22677073 | 2012 | 1 | None | None | SUDS |
| 19841300 | 2009 | 1 | None | 1 | None |
| 19716085 | 2009 | 2 | None | 2 | None |
| 19490272 | 2009 | 17 | None | 17 | None |
| 17470695 | 2007 | 14 | None | 14 | None |
| 17192539 | 2006 | 1 | None | 1 | None |
| 14678125 | 2003 | 13 | None | 13 | None |
| Literature, cohort, and gnomAD | – | 3 | 3 | – | |
| Variant features alone | – | 15 | 3 | 7 | – |
Totals may differ from individual publications due to duplicate patients removed during curation.